Charlesson

Charlesson is a early stage drug development company focused on treating retinal diseases, including diabetic macular edema among others.

Charlesson is a business in diabetes, medical, pharmaceutical based in Southern US, founded in 2004.

Within the diabetes, medical, pharmaceutical space, the company focuses on its core offering rather than a broad product line.

Southern US is where the company is located.

Directory data places it at the Private company stage.

Its team size is recorded as c_00001_00010 employees.

Website: www.charlessonllc.com